Viewing nowRisero Tablets (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 37.06mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

MFDS item code 201404807 · Approved 2014.10.21 · Insurance code 693201140
Treatment and prevention of osteoporosis in postmenopausal women and men
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men. Osteoporosis is a condition where bone density is reduced, leading to an increased risk of fractures. This medication helps improve bone health and reduce the risk of fractures, thereby assisting in maintaining strong bones.
As Risedronate Sodium, an oral dose of 35 mg should be taken once a week. Food interferes with the absorption of this medication; therefore, it should be taken at least 30 minutes before breakfast, or at any time of the day at least 2 hours before or after taking food or drinks to ensure adequate absorption. To help the medication reach the stomach easily and reduce the possibility of esophageal irritation, take it with a sufficient amount of plain water in an upright position.
Safety and efficacy in individuals under 18 have not been established.
This medication can irritate the mucous membranes of the stomach and esophagus, so individuals with upper gastrointestinal diseases should be particularly cautious. If there are issues with the esophagus or difficulty swallowing, discontinue taking this medication and consult a doctor. When taking the medication, it should be consumed with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking it. Continuing to take this medication after experiencing esophageal irritation symptoms may result in serious esophageal issues, so caution is required. Individuals with poor esophageal clearance, hypocalcemia, pregnant or breastfeeding women, and patients with severe renal impairment should not take this medication. It is important to ensure adequate intake of calcium and vitamin D, and if there are pre-existing hypocalcemia or bone metabolic disorders, treatment must be completed before taking this medication. There may be rare side effects such as osteonecrosis of the jaw, so attention should be paid to oral hygiene, and if dental treatment is needed, one should consult with a specialist. With prolonged use, rare atypical fractures such as thigh fractures may occur, so if experiencing leg pain, one should inform a doctor immediately. Taking this medication with other drugs, especially antacids or supplements containing calcium, magnesium, or iron, may interfere with the absorption of this medication, so dosing times should be adjusted. Pregnant or potentially pregnant women and nursing mothers should not take this medication and should consult a doctor if necessary. Safety and efficacy in children under 18 have not been established. Overdose may lead to hypocalcemia, so immediate treatment should be sought if symptoms occur. This medication should be stored out of the reach of children and should not be transferred to another container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound fatigue, liver abnormalities (jaundice), sudden and very severe
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air exposure, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy over time and prevents degradation.
Yellow, rectangular film-coated tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 37.06mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.